Seattle, Washington
United States
14
2015-03-12
10
2015-09-01
These are the the leading inventors for applications assigned to ONCOTHYREON INC.:
ONCOTHYREON INC. based in Seattle, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine
#2 | 2014-09-18COMPOSITIONS AND METHODS OF USING CRYSTALLINE FORMS OF WORTMANNIN ANALOGS
#3 | 2013-05-23Cancer Treatment with Wortmannin Analogs
#4 | 2013-05-23Combination Cancer Therapies with Wortmannin Analogs
#5 | 2012-11-08 ✅ Patent 8,329,639 granted on 2012-12-11MUC1 based glycolipopeptide vaccine with adjuvant
#6 | 2012-10-25 ✅ Patent 8,552,145 granted on 2013-10-08Vaccine for modulating between T1 and T2 immune responses
#7 | 2012-08-30 ✅ Patent 8,889,616 granted on 2014-11-18MUC1 based glycolipopeptide vaccine with adjuvant
#8 | 2012-06-12 ✅ Patent 8,198,400 granted on 2012-06-12Vaccine for modulating between T1 and T2 immune responses
#9 | 2012-02-09METHOD OF MAKING SMALL LIPOSOMES
#10 | 2012-01-05 ✅ Patent 8,097,593 granted on 2012-01-17Lipid A and other carbohydrate ligand analogs
#11 | 2008-06-05 ✅ Patent 9,173,929 granted on 2015-11-03Mucinous glycoprotein (MUC-1) vaccine
#12 | 2007-01-18 ✅ Patent 8,871,250 granted on 2014-10-28Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine
#13 | 2006-08-24 ✅ Patent 7,741,297 granted on 2010-06-22Immunostimulatory, covalently lipidated oligonucleotides
#14 | 2006-02-23 ✅ Patent 7,820,627 granted on 2010-10-26Lipid A and other carbohydrate ligand analogs
Also check out Oncothyreon Inc.'s (Seattle, United States) applicant profile with 1 patent applications submitted.
23971 ⎘